Full text is available at the source.
Abstract
Glioblastoma multiforme has the lowest median overall survival among all malignant brain tumors.
- Current therapeutic strategies for glioblastoma are insufficient, necessitating novel approaches.
- Nanomedicine may enhance drug delivery to the brain, improving treatment outcomes.
- This review focuses on nanomedicine-based delivery strategies tested in animal models.
- Drug candidates currently in clinical use or trials may benefit from these nanotechnology approaches.
- Future perspectives suggest that nanocarriers could play a significant role in glioblastoma treatment.
Simplified